Progesterone in Patients With Placenta Previa

Status Recruiting

Clinical Trial Summary

This study evaluates the efficacy of prophylactic vaginal progesterone administration in reducing of the episodes of antepartum hemorrhage and subsequent prevention of preterm delivery in women with placenta previa.

Clinical Trial Description

Eligible women who consent to participate in the study are randomly allocated into one of the two study groups. Women who are allocated to the study group will receive vaginal progesterone 400 mg [Prontogest® vaginal pessaries 400, Marcyrl, Cairo, Egypt], once at bed time starting from 26-28 weeks of gestation and till 36 weeks of gestation or delivery (which is closer); while the other group will serve as controls. Patients will be followed up till delivery for the incidence in antepartum hemorrhagic episodes. ;

Study Design

Related Conditions & MeSH terms

Placenta Previa

Clinical Trial Details

NCT number	NCT03633175
Study type	Interventional
Source	Ain Shams University
Contact	Mohamed Samy, MD
Phone	01001947488
Email	mohammedsamy8132@gmail.com
Status	Recruiting
Phase	Phase 2
Start date	July 5, 2018
Completion date	August 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04518163` - Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa	N/A
Recruiting	`NCT04518150` - Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section	N/A
Recruiting	`NCT03638024` - Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Terminated	`NCT01996345` - Vaginal Pessary Versus Expectant Management for Placenta Previa	N/A
Recruiting	`NCT04609527` - Management of Placenta Accreta Spectrum	Phase 2/Phase 3
Completed	`NCT03431116` - Low Implanted Second Trimester Placenta and Placenta Previa	N/A
Completed	`NCT03321435` - The Placenta Previa and Fetal Weight	N/A
Enrolling by invitation	`NCT05529381` - Anxiety and Depressive Symptoms in Placenta Previa / Accreta
Completed	`NCT04264234` - Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria	N/A
Completed	`NCT05340205` - Blood Loss During Cesarean Delivery in Placenta Previa Patients	Phase 4
Completed	`NCT03570723` - Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa	N/A
Completed	`NCT05283122` - Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases	N/A
Withdrawn	`NCT01442207` - Cerclage for Prevention on Preterm Birth in Women With Placenta Previa	Phase 3
Not yet recruiting	`NCT03451136` - Cervical Length in Cases of Placenta Previa	N/A
Completed	`NCT02966197` - Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta	N/A
Recruiting	`NCT02590484` - The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta	N/A
Recruiting	`NCT05802251` - Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
Completed	`NCT03542552` - Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa	Phase 3
Recruiting	`NCT03124472` - Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa	N/A
Not yet recruiting	`NCT03208842` - Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar	N/A